Antibody infusion tested in fight against deadly child shock
NCT ID NCT02219165
Summary
This small pilot study tested whether giving intravenous immunoglobulins (IVIG) could help children with life-threatening toxic shock syndrome. The main goal was to see if it's possible to run a larger future trial by checking if enough children could be enrolled and if the treatment plan was practical. The study also looked for early signs that IVIG might improve organ function and survival in these very sick children.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TOXIC SHOCK SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpital Femme Mère Enfant
Bron, 69677, France
Conditions
Explore the condition pages connected to this study.